| Literature DB >> 30281641 |
Jost B Jonas1,2, Wen Bin Wei3, Liang Xu1, Ya Xing Wang1.
Abstract
PURPOSE: Systemic inflammation is potentially associated with ocular diseases such as late age-related macular degeneration (AMD). Using the serum concentration of high-sensitive C-reactive protein (hs-CRP) as surrogate of systemic inflammation, we examined potential associations between the serum hs-CRP concentration and the presence and degree of eye diseases.Entities:
Mesh:
Substances:
Year: 2018 PMID: 30281641 PMCID: PMC6169913 DOI: 10.1371/journal.pone.0204263
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 1Graph showing the distribution of hs-C-reactive protein in the Beijing Eye Study, stratified by the stage of age-related macular degeneration.
Fig 2Graph showing the distribution of hs-C-reactive protein in the Beijing Eye Study, stratified by the stage of diabetic retinopathy.
Associations (univariate analysis) between the serum concentration of hs-C-reactive protein and other systemic and ocular parameters in the Beijing Eye Study.
| Parameter | Mean ± Standard Deviation / Frequency (95% Confidence Intervals) | Standardized Regression Coefficient beta | Non-Standardized Regression Coefficient B | 95% Confidence Interval | |
|---|---|---|---|---|---|
| Age (Years) | 63.4 ± 9.4 | 0.01 | 0.05 | 0.02 | 0.01, 0.04 |
| Gender (Men / Women) | 1032 / 1420 | 0.21 | |||
| Rural / Urban Region of Habitation | 1422 / 1030 | 0.002 | -0.06 | -0.52 | -0.84, -0.19 |
| Body Mass Index (kg/m2) | 25.8 ± 3.9 | <0.001 | 0.11 | 0.11 | 0.07, 0.15 |
| Level of Education (Levels 1–5) | 3.8 ± 1.1 | <0.001 | -0.10 | -0.39 | -0.55, -0.23 |
| Self-Reported Income (Categories: <500 Yuan; -1000; -2000; -3000; -5000; -8000; -10000; >10000) | 3.9 ± 2.2 | <0.001 | -0.07 | -0.14 | -0.21, -0.06 |
| Cognitive Score | 26.2 ± 3.7 | <0.001 | -0.10 | -0.11 | -0.16, -0.07 |
| Alcohol Consumption Frequency | 15.6% (14.0, 17.3) | 0.02 | -0.05 | -0.11 | -0.20, -0.02 |
| Smoking (Never / Former/ Current) | 1671 / 233 / 548 | 0.57 | |||
| Smoking (Never / Ever) | 1671 / 781 | 0.48 | |||
| Smoking Package Years | 10.5 ± 19.6 | 0.13 | |||
| Physical Activity | |||||
| Number of Hours Spent With Vigorously Intensive Physical Activities Per Week | 0.8 ± 5.9 | 0.13 | |||
| Number of Hours Spent With Moderate Physical Activities Per week | 11.7 ± 21.0 | 0.04 | -0.04 | -0.06 | -0.11, -0.002 |
| Number of Hours Spent With Sitting Per Week | 35.3 ± 17.5 | 0.34 | |||
| Number of Hours Spent With Walking Per Week | 16.9 ± 14.5 | 0.33 | |||
| Blood Concentration of: | |||||
| Glucose (mmol/L) | 5.72 ± 1.53 | <0.001 | 0.08 | 0.21 | 0.10, 0.31 |
| Glycosylated Hemoglobin HbA1c (%) | 4.36 ± 1.04 | <0.001 | 0.10 | 0.38 | 0.23, 0.54 |
| High-Density Lipoproteins (mmol/L) | 1.43 ± 0.39 | <0.001 | -0.14 | -1.47 | -1.88, -1.06 |
| Low-Density Lipoproteins (mmol/L) | 3.37 ± 0.87 | 0.86 | |||
| Triglycerides (mmol/L) | 1.62 ± 1.17 | 0.08 | |||
| Cholesterol (mmol/L) | 5.08 ± 0.96 | 0.14 | |||
| Diabetes Mellitus, Frequency | 15.7% (14.3, 17.1) | 0.02 | 0.05 | 0.56 | 0.11, 1.00 |
| Systolic Blood Pressure (mmHg) | 131.7 ± 20.8 | 0.04 | 0.04 | 0.01 | 0, 0.02 |
| Diastolic Blood Pressure (mmHg) | 71.3 ± 12.4 | 0.78 | |||
| Mean Blood Pressure (mmHg) | 91.4 ± 14.1 | 0.25 | |||
| Arterial Hypertension, Frequency | 45.2 (43.2, 47.2) | 0.11 | |||
| Estimated Glomerular Filtration Rate (mL/min / 1·73 m2) (CKDE Formula; China Adapted) | 90.6 ± 12.1 | 0.50 | |||
| Chronic Kidney Disease, Frequency (GFR<60 mL/min / 1·73 m2) (CKDE Formula; China Adapted), Frequency | 2.2% (1.7, 2.8) | 0.39 | |||
| Use of aspirin, Frequency | 29.8% (27.9, 31.6) | 0.05 | 0.04 | 0.36 | -0.005, 0.72 |
| Depression Score | 22.7 ± 5.3 | 0.48 | |||
| Ophthalmological Parameters | |||||
| Axial Length (mm) | 23.1 ± 1.1 | 0.09 | -0.04 | -0.13 | -0.29, 0.02 |
| Anterior Corneal Curvature Radius (mm) | 7.60 ± 0.25 | 0.18 | |||
| Central Corneal Thickness (μm) | 531 ± 33 | 0.26 | |||
| Anterior Chamber Depth (mm) | 2.47 ± 0.46 | 0.44 | |||
| Lens Thickness (mm) | 4.56 ± 0.33 | 0.81 | |||
| Intraocular Pressure mmHg) | 14.6 ± 2.7 | 0.81 | |||
| Retinal Nerve Fiber Layer Thickness (μm) | 101 ± 12 | 0.37 | |||
| Subfoveal Choroidal Thickness (μm) | 261 ± 106 | 0.18 | |||
| Fundus Tessellation (Grades 0–3) | 0.7 ± 0.7 | 0.82 | |||
| Macular Retinal Thickness (μm) | 243 ± 35 | 0.11 | |||
| Optic Disc Size (mm2) | 1.90 ± 0.42 | 0.19 | |||
| Parapapillary Alpha Zone Area (mm2) | 0.48 ± 0.55 | 0.82 | |||
| Parapapillary Beta Zone Area (mm2) | 0.27 ± 1.00 | 0.57 | |||
| Parapapillary Gamma Zone Width (mm) | 0.14 ± 0.59 | 0.47 | |||
| Nuclear Cataract, Frequency | 41.8% (39.7, 44.0) | 0.10 | |||
| Nuclear Cataract, Degree (0–7) | 3.2 ± 1.1 | 0.04 | 0.05 | 0.18 | 0.01, 0.34 |
| Cortical Cataract, Frequency | 16.5% (14.9, 18.1) | 0.05 | 0.04 | 0.48 | -0.001, 0.97 |
| Cortical Cataract, Degree (Percentage of lens Cortical Opacification) | 5.0 ± 14.5 | 0.13 | |||
| Subcapsular Posterior Cataract | 5.6% (4.6, 6.6) | 0.49 | |||
| Subcapsular Posterior Cataract, Degree (Percentage of lens Cortical Opacification) | 0.6 ± 4.3 | 0.07 | |||
| Glaucoma, Frequency, Total | 5.4% (4.5, 6.3) | 0.50 | |||
| Open-Angle Glaucoma, Frequency | 3.4% (2.7, 4.1) | 0.52 | |||
| Primary Angle-Closure Glaucoma | 2.1% (1.5, 2.6) | 0.33 | |||
| Pseudoexfoliation, Frequency | 6.2% (5.2, 7.2) | 0.56 | |||
| Age-Related Macular Degeneration, Frequency, Total | 26.6% (24.9, 28.4) | 0.71 | |||
| Age-Related Macular Degeneration as Ordinal Parameter | 1804 / 196 / 437 / 17 | 0.36 | |||
| Age-Related Macular Degeneration, Early Stage, Frequency | 8.0% (7.0, 9.0) | 0.42 | |||
| Age-Related Macular Degeneration, Intermediate Stage, Frequency | 17.9% (16.0, 19.0) | 0.50 | |||
| Age-Related Macular Degeneration, Late Stage, Frequency | 0.7% (0.0, 1.0) | 0.06 | |||
| Age-Related Macular Degeneration, Late Stage; Geographic Atrophy, Frequency | 0.3% (0.0, 0.1) | 0.84 | |||
| Age-Related Macular Degeneration, Late Stage; Neovascular Stage, Frequency | 1.3% (1.0, 2.0) | 0.04 | 0.04 | 1.03 | 0.03, 2.03 |
| Diabetic Retinopathy, Frequency | 3.5% (2.9, 4.3) | 0.003 | 0.06 | 1.33 | 0.47, 2.19 |
| Retinal Vein Occlusion, Total, Frequency | 2.9% (2.2, 3.5) | 0.53 | |||
| Central Serous Choroidopathy, Frequency | 0.2% (0.003, 0.04) | 0.38 | |||
| Polypoidal Choroidal Vasculopathy, Frequency | 4 / 2452 (0.2% (0.00, 0.00)) | 0.002 | 0.06 | 6.29 | 2.29, 10.28 |
Associations (multivariate analysis) between the serum concentration of hs-C-reactive protein and other systemic and ocular parameters in the Beijing Eye Study.
| Parameter | Standardized Regression Coefficient beta | Non-Standardized Regression Coefficient B | 95% Confidence Interval | Variance Inflation Factor | |
|---|---|---|---|---|---|
| Diabetic Retinopathy (ETDRS Level) | 0.007 | 0.06 | 1.35 | 0.37, 2.22 | 1.01 |
| Polypoidal Choroidal Vasculopathy | 0.002 | 0.06 | 6.22 | 2.24, 10.2 | 1.00 |
| Serum Concentration of High-Density Lipoproteins (mmol/L) | <0.001 | -0.12 | -1.31 | -1.77, -0.85 | 1.15 |
| Cognitive Score | 0.01 | -0.07 | -0.08 | -0.13, -0.02 | 1.56 |
| Level of Education | 0.035 | -0.06 | -0.22 | -0.42, -0.02 | 1.62 |
| Body Mass Index (kg/m2) | 0.01 | 0.06 | 0.06 | 0.01, 0.11 | 1.18 |